RecruitingNCT06967831
Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells
Studying Leigh syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Charite University, Berlin, Germany
- Principal Investigator
- Markus Schuelke, MDCHARITE - UNIVERSITAETSMEDIZIN BERLIN
- Intervention
- skin biopsy(procedure)
- Enrollment
- 80 enrolled
- Eligibility
- All sexes
- Timeline
- 2020 – 2030
Study locations (2)
- Universitätsklinikum Düsseldorf, Düsseldorf, North Rhine-Westphalia, Germany
- Charite - Universtaetsmedizin Berlin, Berlin, State of Berlin, Germany
Collaborators
European Union · German Research Foundation · German Federal Ministry of Education and Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06967831 on ClinicalTrials.govOther trials for Leigh syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE2NCT06843811Sirolimus for Leigh SyndromeMatthew Demczko
- RECRUITINGNANCT03137355The International Registry for Leigh SyndromeThe University of Texas Health Science Center, Houston
- RECRUITINGNCT01780168The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of MetabolismNational Human Genome Research Institute (NHGRI)